Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 9:45 AM ISTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA Farhat Nasim8 Nov 2019 10:00 AM ISTErlotinib Tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug (RLD) TARCEVA used in the treatment of patients with...
New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 4:20 PM ISTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial Medical Dialogues Bureau3 Nov 2019 9:00 AM ISTBristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA Medical Dialogues Bureau2 Nov 2019 9:30 AM ISTZantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
Mirati Therapeutics oral drug MRTX849 shrinks tumours in early-stage trial Medical Dialogues Bureau2 Nov 2019 9:00 AM ISTOut of 17 patients enrolled in the Phase 1 trial of Mirati Therapeutics' oral drug MRTX849, 12 have been evaluated, including six with lung cancer and...
AstraZeneca sells European rights for schizophrenia drug Seroquel, Seroquel XR for USD 178 million Farhat Nasim30 Oct 2019 5:25 PM ISTThe treatment, Seroquel, and another version, Seroquel XR, have lost patent protection in Europe and Russia, AstraZeneca said. The drug variants are...
New tests shows NO sign of asbestos in recalled JnJ baby powder Medical Dialogues Bureau30 Oct 2019 1:18 PM ISTBut Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
Pfizer cancer drug Ibrance higher sales beat Q3 profit estimates Medical Dialogues Bureau30 Oct 2019 9:30 AM ISTPfizer said it expects to earn between $2.94 per share and $3.00 per share, up from a prior estimate of $2.76 to $2.86. Analysts on average were...
Dr Reddys gets CDSCO Committee recommendation for approval for additional indications of Desosumab Farhat Nasim26 Oct 2019 2:38 PM ISTRecently, the Hyderabad-based Dr Reddy's Labs presented its proposal before the CDSCO Committee for an additional indication for Denosumab 120...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 10:00 AM ISTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
Dr Reddys recalls Ranitidine products in US over cancer-causing impurity Medical Dialogues Bureau24 Oct 2019 9:30 AM ISTThis recall follows the USFDA's caution note alerting patients and healthcare professionals that NDMA was found in certain samples of ranitidine, Dr...
